215 related articles for article (PubMed ID: 38145335)
41. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
[TBL] [Abstract][Full Text] [Related]
42. The bidirectional roles of the cGAS-STING pathway in pain processing: Cellular and molecular mechanisms.
Hu Y; Chen Y; Liu T; Zhu C; Wan L; Yao W
Biomed Pharmacother; 2023 Jul; 163():114869. PubMed ID: 37182515
[TBL] [Abstract][Full Text] [Related]
43. The cGAS-STING Pathway: A Ubiquitous Checkpoint Perturbing Myocardial Attributes.
Wan X; Tian J; Hao P; Zhang J; Zhou Y; Ge C; Song X
Curr Vasc Pharmacol; 2023; 21(3):152-162. PubMed ID: 37138486
[TBL] [Abstract][Full Text] [Related]
44. RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing.
Webb LG; Fernandez-Sesma A
Curr Opin Virol; 2022 Apr; 53():101206. PubMed ID: 35180533
[TBL] [Abstract][Full Text] [Related]
45. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
Dan Q; Yang Y; Ge H
Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
[TBL] [Abstract][Full Text] [Related]
46. The cGAS-STING pathway: a therapeutic target in diabetes and its complications.
He W; Mu X; Wu X; Liu Y; Deng J; Liu Y; Han F; Nie X
Burns Trauma; 2024; 12():tkad050. PubMed ID: 38312740
[TBL] [Abstract][Full Text] [Related]
47. Potential cGAS-STING pathway functions in DNA damage responses, DNA replication and DNA repair.
Zierhut C
DNA Repair (Amst); 2024 Jan; 133():103608. PubMed ID: 38056369
[TBL] [Abstract][Full Text] [Related]
48. The role of chemerin in the regulation of cGAS-STING pathway in gestational diabetes mellitus placenta.
Zhou X; Zhang H; Jiang Y; Wei L; Chen Y; Zhang J; Gao P; Zhu S; Fang C; Du Y; Su R; He M; Yu J; Wang S; Ding W; Feng L
FASEB J; 2023 Mar; 37(3):e22806. PubMed ID: 36786722
[TBL] [Abstract][Full Text] [Related]
49. cGAS/STING Pathway Activation Contributes to Delayed Neurodegeneration in Neonatal Hypoxia-Ischemia Rat Model: Possible Involvement of LINE-1.
Gamdzyk M; Doycheva DM; Araujo C; Ocak U; Luo Y; Tang J; Zhang JH
Mol Neurobiol; 2020 Jun; 57(6):2600-2619. PubMed ID: 32253733
[TBL] [Abstract][Full Text] [Related]
50. Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells.
He Y; Yang Y; Huang W; Yang S; Xue X; Zhu K; Tan H; Sun T; Yang W
Int J Radiat Biol; 2023; 99(12):1890-1907. PubMed ID: 37406172
[TBL] [Abstract][Full Text] [Related]
51. Novel insight into cGAS-STING pathway in ischemic stroke: from pre- to post-disease.
Ma X; Xin D; She R; Liu D; Ge J; Mei Z
Front Immunol; 2023; 14():1275408. PubMed ID: 37915571
[TBL] [Abstract][Full Text] [Related]
52. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases.
Liu J; Rui K; Peng N; Luo H; Zhu B; Zuo X; Lu L; Chen J; Tian J
Cytokine Growth Factor Rev; 2022 Dec; 68():69-80. PubMed ID: 36151014
[TBL] [Abstract][Full Text] [Related]
53. Nanoformulations of chemotherapeutic activators of the cGAS-STING pathway in tumor chemoimmunotherapy.
Wang L; Yu Z; Zhang J; Guo J
Drug Discov Today; 2024 Mar; 29(3):103892. PubMed ID: 38272174
[TBL] [Abstract][Full Text] [Related]
54. Regulation of cGAS and STING signaling during inflammation and infection.
Chauvin SD; Stinson WA; Platt DJ; Poddar S; Miner JJ
J Biol Chem; 2023 Jul; 299(7):104866. PubMed ID: 37247757
[TBL] [Abstract][Full Text] [Related]
55. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
[TBL] [Abstract][Full Text] [Related]
56. Progress in understanding the role of cGAS-STING pathway associated with programmed cell death in intervertebral disc degeneration.
Wang Z; Hu X; Cui P; Kong C; Chen X; Wang W; Lu S
Cell Death Discov; 2023 Oct; 9(1):377. PubMed ID: 37845198
[TBL] [Abstract][Full Text] [Related]
57. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J; Yu S; Peng Q; Wang P; Fang L
Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
[TBL] [Abstract][Full Text] [Related]
58. The cGAS-STING pathway and cancer.
Samson N; Ablasser A
Nat Cancer; 2022 Dec; 3(12):1452-1463. PubMed ID: 36510011
[TBL] [Abstract][Full Text] [Related]
59. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
[TBL] [Abstract][Full Text] [Related]
60. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
Zhu C; Li J; Yao M; Fang C
BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
